Molecular Advances Offer New Tools, New Hope For Cancer Studies

Sidebar: Cancer Resources The field of cancer research has been dramatically altered by advances in molecular biology. In some cases, investigators can tease out the precise molecular route by which cells turn cancerous and how those calls are affected by treatments. Researchers are working to understand the nuances of oncogenes, or cancer-causing genes. Others have located cancer susceptibility genes, providing hope for future screening methods and potential treatments. As scientists continue

Written bySteven Benowitz
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

Sidebar: Cancer Resources


GROWING FIELD: Cancer genetics has "blossomed in the last few years," notes American Cancer Society’s Harmon Eyre.
"The whole field of genetic understanding of cancer has blossomed in the last few years," says Harmon Eyre, executive vice president of research and cancer control at the American Cancer Society in Atlanta. "This includes the mapping of the human genome, and the isolation of the oncogenes and tumor suppressor genes."


PREVENTIVE EMPHASIS: Columbia’s Frederica Perera says identifying causal factors is a key to effective intervention.
One new field that has developed in recent years is molecular epidemiology. Taking advantage of scientists' ability to peer within DNA and cells, researchers such as Frederica Perera, a professor of environmental health sciences at Columbia School of Public Health, search for biological signposts of heightened cancer risk.

"We need more emphasis on preventing cancer by identifying causal factors early on to be able ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies